Heal
-
DATABASE (312)
-
ARTICLES (3)
Headquartered in Hong Kong, Summer Capital was founded by senior UBS banker Joseph Chee in 2015. Focused on both public and private investments, it mainly invests in sectors of healthcare, consumer products, education, logistics and fintech.
Headquartered in Hong Kong, Summer Capital was founded by senior UBS banker Joseph Chee in 2015. Focused on both public and private investments, it mainly invests in sectors of healthcare, consumer products, education, logistics and fintech.
Focused on life sciences, OrbiMed has been investing in the global healthcare industry for over 20 years. Its portfolio ranges from early-stage startups to multinational corporations. With more than 100 scientific, medical, and investment professionals, it manages over $17bn assets worldwide.
Focused on life sciences, OrbiMed has been investing in the global healthcare industry for over 20 years. Its portfolio ranges from early-stage startups to multinational corporations. With more than 100 scientific, medical, and investment professionals, it manages over $17bn assets worldwide.
The owner of WeChat, Tencent is China's biggest online entertainment and social network company. While the company is best known for QQ and WeChat (with 846m active users, and counting), online gaming is actually its biggest money-spinner. Within China, Tencent is the distributor of various international online game titles, such as League of Legends and Call of Duty Online. The company also publishes Honor of Kings, known as Arena of Valor outside China, which regularly tops the list of highest-grossing mobile games globally.Tencent has invested in various gaming-related companies, including Epic Games (creator of Fortnite and the Unreal Engine creation framework), PlatinumGames (Japanese game developer), and Riot Games (creator of League of Legends). Outside of video games, it has developed and invested in products related to video streaming, such as bilibili and Kuaishou, music (JOOX), and even healthcare.
The owner of WeChat, Tencent is China's biggest online entertainment and social network company. While the company is best known for QQ and WeChat (with 846m active users, and counting), online gaming is actually its biggest money-spinner. Within China, Tencent is the distributor of various international online game titles, such as League of Legends and Call of Duty Online. The company also publishes Honor of Kings, known as Arena of Valor outside China, which regularly tops the list of highest-grossing mobile games globally.Tencent has invested in various gaming-related companies, including Epic Games (creator of Fortnite and the Unreal Engine creation framework), PlatinumGames (Japanese game developer), and Riot Games (creator of League of Legends). Outside of video games, it has developed and invested in products related to video streaming, such as bilibili and Kuaishou, music (JOOX), and even healthcare.
American private equity firm Warburg Pincus was established in 1966 and has since invested more than $55bn in more than 750 companies in more than 40 countries around the world. So far, the company has raised 19 private equity funds with over $90bn in assets under management. Its investment portfolio can be divided geographically into Asia, Europe, and the Americas. Its Asian portfolio includes tech companies, real estate, healthcare and more verticals, with many Chinese companies featured on the list.
American private equity firm Warburg Pincus was established in 1966 and has since invested more than $55bn in more than 750 companies in more than 40 countries around the world. So far, the company has raised 19 private equity funds with over $90bn in assets under management. Its investment portfolio can be divided geographically into Asia, Europe, and the Americas. Its Asian portfolio includes tech companies, real estate, healthcare and more verticals, with many Chinese companies featured on the list.
Allianz X is the venture capital arm of Allianz Group. Its investments primarily focus on insurance, healthcare and finance-related tech startups, such as American Well, BIMA (micro-insurance company) and Simplesurance. However, it recently made investments in Indonesian ride-hailing startup Gojek as well as the Drone Racing League, a startup that promotes drone racing as an emerging sport.
Allianz X is the venture capital arm of Allianz Group. Its investments primarily focus on insurance, healthcare and finance-related tech startups, such as American Well, BIMA (micro-insurance company) and Simplesurance. However, it recently made investments in Indonesian ride-hailing startup Gojek as well as the Drone Racing League, a startup that promotes drone racing as an emerging sport.
NGP Capital was founded in 2005 with Nokia and Bell Labs as its limited partners. It has investment teams in Asia (India and China), North America and Europe. It invests mainly in growth-stage companies with typical investments ranging from $8m–$12m.With more than $1.2bn under management, NGP Capital's portfolio includes Xiaomi, Deliveroo and UCweb. As of July 2019, NGP Capital had invested in more than 90 companies, including eight IPOs and 33 M&As. It focuses also on mobility and digital health sectors.
NGP Capital was founded in 2005 with Nokia and Bell Labs as its limited partners. It has investment teams in Asia (India and China), North America and Europe. It invests mainly in growth-stage companies with typical investments ranging from $8m–$12m.With more than $1.2bn under management, NGP Capital's portfolio includes Xiaomi, Deliveroo and UCweb. As of July 2019, NGP Capital had invested in more than 90 companies, including eight IPOs and 33 M&As. It focuses also on mobility and digital health sectors.
TI Platform Management is a US-based investment firm founded by Alex Bangash and Trang T Nguyen, who are also the founders of LP network and investment news platform TrustedInsight. Founded in 2015, the firm seeks out disruptive business models and invests in a range of categories, from furniture and home construction to healthcare and deep-tech. It has invested in Singapore-based enzyme engineering startup Allozymes, B2B pharmacy fulfillment service TruePill, and supply chain management startup Tyltgo.
TI Platform Management is a US-based investment firm founded by Alex Bangash and Trang T Nguyen, who are also the founders of LP network and investment news platform TrustedInsight. Founded in 2015, the firm seeks out disruptive business models and invests in a range of categories, from furniture and home construction to healthcare and deep-tech. It has invested in Singapore-based enzyme engineering startup Allozymes, B2B pharmacy fulfillment service TruePill, and supply chain management startup Tyltgo.
Khosla Ventures is a Silicon Valley-based VC, founded in 2004 by Indian-born founder of tech pioneer Sun Microsystems Vinod Khosla. The company has no specific interest in terms of sector but heavily favors “large problems that are amenable to technology solutions” and invests in so-called high potential 'black swans´. Healthcare is a strong focus and its most recent investments include in the Portuguese home physiotherapy tech solution SWORD Health's 2021 $85m Series C and $25m Series B rounds besides its 2020 $17m Series A round which it led. Khosla has over $5bn under management and more than 70 staff, with investments in more than 700 startups, leading more than one-third. Other recent investments include in the July 2021 $75m Series C round of Indian personal health and fitness app HealthifyMe and, the same month, in the $12.5m Series A round of US commercial real estate app for tenants and property managers Jones.
Khosla Ventures is a Silicon Valley-based VC, founded in 2004 by Indian-born founder of tech pioneer Sun Microsystems Vinod Khosla. The company has no specific interest in terms of sector but heavily favors “large problems that are amenable to technology solutions” and invests in so-called high potential 'black swans´. Healthcare is a strong focus and its most recent investments include in the Portuguese home physiotherapy tech solution SWORD Health's 2021 $85m Series C and $25m Series B rounds besides its 2020 $17m Series A round which it led. Khosla has over $5bn under management and more than 70 staff, with investments in more than 700 startups, leading more than one-third. Other recent investments include in the July 2021 $75m Series C round of Indian personal health and fitness app HealthifyMe and, the same month, in the $12.5m Series A round of US commercial real estate app for tenants and property managers Jones.
Founders Fund is a San Francisco-based VC set up in 2005 that currently has more than $3bn of assets under management. It invests across the tech, aerospace and biotechnology sectors and has been an early backer of some of the most impactful tech companies including Airbnb, Facebook, and SpaceX. It has a key interest in solving major problems such as the opioid crisis in the US.Its recent investments include in the June 2021 $85m Series C round of Portuguese home physiotherapy tech solution SWORD Health, the world’s fastest-growing musculoskeletal solution, and in the July 2021 $80m Series C round of residential real estate platform Sundae. The company has managed over 80 exits including Facebook and Spotify and has made over 500 investments, leading approximately one-third of these.
Founders Fund is a San Francisco-based VC set up in 2005 that currently has more than $3bn of assets under management. It invests across the tech, aerospace and biotechnology sectors and has been an early backer of some of the most impactful tech companies including Airbnb, Facebook, and SpaceX. It has a key interest in solving major problems such as the opioid crisis in the US.Its recent investments include in the June 2021 $85m Series C round of Portuguese home physiotherapy tech solution SWORD Health, the world’s fastest-growing musculoskeletal solution, and in the July 2021 $80m Series C round of residential real estate platform Sundae. The company has managed over 80 exits including Facebook and Spotify and has made over 500 investments, leading approximately one-third of these.
Green Innovations is an impact fund that invests in large-scale projects addressing global sustainability challenges, focusing on the agriculture, biotechnology, education, energy, housing and water sectors. It is headed by Angola-based Portuguese businessman Jorge Marques, and linked to Israeli group Mitrelli. Green Innovations took control of Biocant, Portugal’s biggest biotech park, in a privatization move in 2017–2018. Green Innovations's stable of companies includes Green Biotech, created to invest in biotechnology in Portugal, and Green Services Innovations, linked to the exploration of phosphates in Congo.Its recent investments include in the June 2021 $85m Series C round and February 2021 $25m Series B of Portuguese home physiotherapy tech solution SWORD Health, the world’s fastest-growing musculoskeletal solution.
Green Innovations is an impact fund that invests in large-scale projects addressing global sustainability challenges, focusing on the agriculture, biotechnology, education, energy, housing and water sectors. It is headed by Angola-based Portuguese businessman Jorge Marques, and linked to Israeli group Mitrelli. Green Innovations took control of Biocant, Portugal’s biggest biotech park, in a privatization move in 2017–2018. Green Innovations's stable of companies includes Green Biotech, created to invest in biotechnology in Portugal, and Green Services Innovations, linked to the exploration of phosphates in Congo.Its recent investments include in the June 2021 $85m Series C round and February 2021 $25m Series B of Portuguese home physiotherapy tech solution SWORD Health, the world’s fastest-growing musculoskeletal solution.
Woodford Patient Capital Trust
The Woodford Patient Capital Trust is part of the larger group Woodford Funds. The company is based in Oxford and was formed in 2014, headed by veteran fund manager Neil Woodford. The Patient Capital Trust focuses on early- and early-growth-stage companies, with target returns of more than 10% yearly. The bulk of their portfolio comprises healthcare companies.
The Woodford Patient Capital Trust is part of the larger group Woodford Funds. The company is based in Oxford and was formed in 2014, headed by veteran fund manager Neil Woodford. The Patient Capital Trust focuses on early- and early-growth-stage companies, with target returns of more than 10% yearly. The bulk of their portfolio comprises healthcare companies.
With currently over $21bn of AUM, Baring Private Equity Asia (BPEA) was started in Hong Kong in 1997 by Jean Eric Salata, as the regional Asian PE investment arm of UK-based Baring Private Equity Partners. With $300m in its first fund, it focused on riding China’s economic rise spurred by the country’s market liberalization. In 2000, Salata led a management buyout of BPEA and continues to head the firm today as CEO and Founding Partner. BPEA has invested in more than 100 companies, across healthcare, logistics, IT services, media, education, financial services and retail. It is one of the largest independent PE firms in Asia and has eight offices across the continent.With offices in China, India, Japan, Australia, and Singapore, it currently has around 43 portfolio companies, almost all Asia-based, across multiple business segments in tech and non-tech startups, especially in bricks-and-mortar education establishments. It also makes acquisitions, including most recently of US outsourcing services company Virtusa in February 2021.Other recent investments include in the June 2021 $85m Series C round of Portuguese home physiotherapy tech solution SWORD Health, the world’s fastest-growing musculoskeletal solution, and in the November 2020 $198m Series D round of Chinese computer coding for kids edtech Codemao.
With currently over $21bn of AUM, Baring Private Equity Asia (BPEA) was started in Hong Kong in 1997 by Jean Eric Salata, as the regional Asian PE investment arm of UK-based Baring Private Equity Partners. With $300m in its first fund, it focused on riding China’s economic rise spurred by the country’s market liberalization. In 2000, Salata led a management buyout of BPEA and continues to head the firm today as CEO and Founding Partner. BPEA has invested in more than 100 companies, across healthcare, logistics, IT services, media, education, financial services and retail. It is one of the largest independent PE firms in Asia and has eight offices across the continent.With offices in China, India, Japan, Australia, and Singapore, it currently has around 43 portfolio companies, almost all Asia-based, across multiple business segments in tech and non-tech startups, especially in bricks-and-mortar education establishments. It also makes acquisitions, including most recently of US outsourcing services company Virtusa in February 2021.Other recent investments include in the June 2021 $85m Series C round of Portuguese home physiotherapy tech solution SWORD Health, the world’s fastest-growing musculoskeletal solution, and in the November 2020 $198m Series D round of Chinese computer coding for kids edtech Codemao.
Founded in Boston in 2019, Transformation is entirely dedicated to healthcare disruption, predominently focuses on US investments and typically invests $10-30m per startup. It currently has 22 companies in its portfolio. Its most recent investments include in the June 2021 $85m Series C round of Portuguese home physiotherapy tech solution SWORD Health, the world’s fastest-growing musculoskeletal solution, and, the same month, in the $21m Series D round of Protenus, the US’ leading healthcare compliance analytics firm.
Founded in Boston in 2019, Transformation is entirely dedicated to healthcare disruption, predominently focuses on US investments and typically invests $10-30m per startup. It currently has 22 companies in its portfolio. Its most recent investments include in the June 2021 $85m Series C round of Portuguese home physiotherapy tech solution SWORD Health, the world’s fastest-growing musculoskeletal solution, and, the same month, in the $21m Series D round of Protenus, the US’ leading healthcare compliance analytics firm.
Vesalius Biocapital III is a €70 million fund that invests in medtech, e-health initiatives and drug development in Europe. It was launched in 2017 by Luxembourg-based Vesalius Biocapital, a life sciences venture capital firm founded in 2007. Preceding Vesalius Biocapital III were Vesalius Biocapital I, with €76 million under management and Vesalius Biocapital II, which has €78 million invested; both funds have 11 portfolio companies each.Its recent investments include in Portuguese home physiotherapy tech solution SWORD Health's 2021 $25m Series B and in the 2020 $9m second phase of its Series A round as well as in the 2020 €22m Series B round of German biotech Topas Therapeutics.
Vesalius Biocapital III is a €70 million fund that invests in medtech, e-health initiatives and drug development in Europe. It was launched in 2017 by Luxembourg-based Vesalius Biocapital, a life sciences venture capital firm founded in 2007. Preceding Vesalius Biocapital III were Vesalius Biocapital I, with €76 million under management and Vesalius Biocapital II, which has €78 million invested; both funds have 11 portfolio companies each.Its recent investments include in Portuguese home physiotherapy tech solution SWORD Health's 2021 $25m Series B and in the 2020 $9m second phase of its Series A round as well as in the 2020 €22m Series B round of German biotech Topas Therapeutics.
Future Positive Capital is a Paris-based VC with a second office in London. Its investments cover deep-technology companies applying AI, biotechnology, synthetic biology, as well as robotics. Co-funded in 2016 by ex-Index Ventures associate Sofia Hmich along with Alexandre Terrien and Michael Rosen; it has made 18 investments to date. In 2019 Future Positive raised over $57m pan-European impact investment fund, claiming that most European VCs are continuing to staying focused on sectors, such as consumer, fintech, and marketing, or web and mobile technologies. Future Positive’s belief is that there is instead, a long-tail of investment opportunities to back businesses that actually tackle “the world’s most pressing problems”.Through this fund, it will back throughout Seed and Series A stages, with the possibility to follow up on Series B investing between around €300,000 and €5m. Since then the company has backed startups in the like of BioBeats, an AI company focused on preventative mental health, cell-based startup Meatable, and more recently NotCo, the Chilean unicorn disrupting the food and beverage sector with AI-enabled plant-based products.The team counts on an extensive network of mentors, innovators, impact angel investors and entrepreneurs such as F1 pilots Nico Rosberg, the MD of Alibaba France Sebastien Badault, the Omid Ashtari the President of Citymapper amongst others.
Future Positive Capital is a Paris-based VC with a second office in London. Its investments cover deep-technology companies applying AI, biotechnology, synthetic biology, as well as robotics. Co-funded in 2016 by ex-Index Ventures associate Sofia Hmich along with Alexandre Terrien and Michael Rosen; it has made 18 investments to date. In 2019 Future Positive raised over $57m pan-European impact investment fund, claiming that most European VCs are continuing to staying focused on sectors, such as consumer, fintech, and marketing, or web and mobile technologies. Future Positive’s belief is that there is instead, a long-tail of investment opportunities to back businesses that actually tackle “the world’s most pressing problems”.Through this fund, it will back throughout Seed and Series A stages, with the possibility to follow up on Series B investing between around €300,000 and €5m. Since then the company has backed startups in the like of BioBeats, an AI company focused on preventative mental health, cell-based startup Meatable, and more recently NotCo, the Chilean unicorn disrupting the food and beverage sector with AI-enabled plant-based products.The team counts on an extensive network of mentors, innovators, impact angel investors and entrepreneurs such as F1 pilots Nico Rosberg, the MD of Alibaba France Sebastien Badault, the Omid Ashtari the President of Citymapper amongst others.
Neurafarm: Putting an AI plant doctor in farmers' hands
This startup is riding on Indonesia’s urban farming trend with its planting kit and an AI-powered app that identifies plant diseases from photos of unhealthy leaves
HypeLabs wins bumper US$3m seed funding to democratize connectivity
HypeLab's P2P mesh networking technology enables everyone to communicate within their own networks without needing internet, in cities, remote villages and even in disaster zones
Knokcare: Telemedicine app connects you to doctors in 30 minutes
Seeking funding of over €1m, Portugal’s digital healthcare pioneer is expanding its SaaS to tap new markets in Europe, Africa and Latin America
Sorry, we couldn’t find any matches for “Heal”.
POPULAR DATABASE
